Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KRRO

Korro Bio, Inc.

CIK 0001703647 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$13.18
↑ 0.22 (1.70%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$194.08M
P/E Ratio
-1.82
EPS
-12.48
Dividend Yield
Not covered
52W Position
16%
Beta
2.96

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.88
P/S
81.48
EV/Revenue
71.02
ROE
-103.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 16%
$5.20$55.89

Latest Financials

2025-12-31 FY
Revenue
$6.39M
Net Income
-$117.26M
Total Assets
$113.51M
Free Cash Flow
-$79.08M

Recent news